Another critical organizer of b-AR signalling integration is constituted by A-kinase anchoring proteins (AKAPs). In cardiomyocytes, AKAPs target PKA to the plasma membrane, the sarcoplasmic reticulum and the myofilaments for local regulation of major ECC proteins. 14 AKAPs also target PKA to other intracellular organelles such as the nucleus to regulate gene expression. 14, 15 In cardiomyocytes, the scaffold protein muscle AKAPb (mAKAPb) organizes a complete cAMP signalling module including PKA and PDE4D3 at the nuclear envelope. Because PDE4D3 is phosphorylated and activated by PKA 16 this constitutes a negative feedback loop modulating local cAMP level and PKA activity. 17 Several subsequent studies showed that mAKAPb assemble a much larger signalosome which major function is to modulate pathological hypertrophy. [18] [19] [20] Upon b-AR stimulation and cAMP elevation, PKA activation also drives CREB-dependent transcriptional activation of inducible cAMP early repressor (ICER), a potent pro-apoptotic factor in cardiomyocytes. 21, 22 In addition, PKA regulates Class II histone deacetylases 4
and 5 in the nucleus. [23] [24] [25] However, thus far the mechanisms that control the dynamics of nuclear PKA activity in cardiomyocytes remain poorly understood. We and others have used geneticallyencoded PKA biosensors targeted to the cytoplasm and the nucleus to show temporal segregation of PKA responses in both compartments in neonatal and adult cardiomyocytes. 26, 27 Such organization provides a mechanism by which acute b-AR stimulation may regulate contractility independently of gene expression. Our previous results also identified PDE4 as an important upstream regulator of nuclear PKA activity upon b-AR stimulation. However, how cAMP/ PKA signalling generated by b 1 -and b 2 -ARs are integrated in the nucleus of cardiomyocytes and whether this participates in functional differences observed upon stimulation of these receptors remains elusive. Here, we reveal that b 1 -and b 2 -ARs differentially regulate nuclear PKA activity and ICER expression in adult cardiomyocytes. We provide evidence that PDE4 prevents activation by b 2 -ARs of a mAKAPb-targeted PKA pool at the nuclear envelope which is required for PKA activation inside the nucleus and contributes to ICER induction.
Methods
An expanded methods section is provided in the Data Supplementary material online.
Experimental animals
All procedures were performed in accordance with the European Community guiding principles in the Care and Use of Animals (2010/63/UE), the local Ethics Committee (CREEA Ile-de-France Sud) guidelines and the French decree no. 2013-118 on the protection of animals used for scientific purposes. Male Wistar rats were anaesthetized by intraperitoneal injection of pentobarbital (0.1 mg/g).
FRET-based cAMP and PKA measurements in adult rat ventricular myocytes
After transduction of freshly isolated adult rat ventricular myocytes (ARVMs) with the appropriate adenoviruses, cells were subjected to Förster resonance energy transfer (FRET) measurements as described in. 26 
Results

b 1 -and b 2 -ARs differentially regulate nuclear PKA activity in adult cardiomyocytes
To analyse the dynamics of PKA activity in the bulk cytoplasm and in the nucleus, we used genetically encoded A-kinase activity reporters (AKAR3) targeted to these compartments by the addition of a nuclear export sequence (NES), and a nuclear localizing sequence (NLS), respectively. 28 As shown previously in 26 and in the pseudocolour images of Figure 1 , adenoviral transfer allowed robust and compartment-specific expression of these biosensors after 24 h in ARVMs.
To determine how b 1 -and b 2 -ARs regulate cytoplasmic and nuclear PKA activities in ARVMs, we selectively stimulated these two receptors using a combination of isoprenaline (Iso) and either the b 2 -AR antagonist ICI 118, 551 (ICI, 10 nM) or the b 1 -AR antagonist CGP 20712 A (CGP, 100 nM), respectively. Stimulation of cytoplasmic PKA activity by b 1 -and b 2 -ARs were completely abolished by 100 nM CGP and 10 nM ICI, respectively, indicating that the chosen concentrations of ICI and CGP in combination with Iso were appropriate for selective stimulation of b-AR subtypes (see Supplementary material online, Figure S1 ). b 1 -AR stimulation led to a fast increase in cytoplasmic PKA activity and a robust, but slower increase in nuclear PKA activity ( Figure 1A and B). In contrast, b 2 -AR stimulation increased cytoplasmic PKA activity but had negligible effects on nuclear PKA activity ( Figure 1C and D) . As shown in Figure 1E , b 1 -AR stimulation increased PKA activity in a concentration-dependent manner in both compartments, whereas this occurred only in the cytoplasm with b 2 -AR stimulation ( Figure 1F) . In Figure 1G , nuclear PKA activation was plotted as a function of cytoplasmic PKA activation for the two receptors. The steeper slope of the linear regression further illustrates that b 1 -ARs are more efficient than b 2 -ARs to increase nuclear PKA activity, even when cytoplasmic PKA is activated at the same level.
b 1 -and b 2 -ARs elevate cAMP in the nucleus
Because cAMP generated by b 2 -ARs was reported to be locally confined, 29 we hypothesized that cAMP may not reach the nucleus upon b 2 -AR stimulation, hence explaining the lack of PKA activation in this compartment. To test this hypothesis, we generated a nuclear-targeted version of the cytoplasmic cAMP sensor Epac-S H187 by addition of 3 NLS at the C-terminus (Epac-S H187 -3NLS). 30 Adenoviral vectors allowed robust and compartment-specific expression of Epac-S H187 and Epac-S H187 -3NLS in ARVMs at 24 h (see Supplementary material online, Figure  S2A ). As shown by the individual traces in Figure 2A -D and summarized in Figure 2E and F, stimulation of both b 1 -and b 2 -ARs increased cAMP in a concentration-dependent manner in the two compartments. Regardless of the receptor type or the Iso concentration employed, the FRET responses recorded in the nucleus were systematically higher than in the cytoplasm. This difference apparently reflected a greater sensitivity of the 3NLS version of the sensor to cAMP and not higher cAMP levels in the nucleus. When the changes in FRET induced by Iso in the cytoplasm were determined for both sensors following expression for 48 h, a condition for which the Epac-S H187 -3NLS sensor became expressed not only in the nucleus, but also in the cytoplasm (see Supplementary material online, Figure S2B ), the cytoplasmic response of the mislocalized Epac-S H187 -3NLS sensor to Iso was higher than that measured with Epac-S H187 (see Supplementary material online, Figure S2C) . 
sensors, the relative response in the cytoplasmic and nuclear compartments did not differ between b 1 -and b 2 -ARs ( Figure 2G ), in contrast to what was observed with the PKA sensors ( Figure 1G ). Thus the lack of nuclear PKA activation cannot be attributed to the absence of a global nuclear cAMP elevation upon b 2 -AR stimulation.
Mechanisms that prevent nuclear PKA activation by b 2 -ARs
Multiple mechanisms have been proposed to compartmentalize b 2 -AR activation of PKA, by acting not only on cAMP generation and propagation but also downstream. In particular, receptor coupling to G i may not only temper cAMP synthesis, but also activate alternative signalling pathways through bc to circumvent the concurrent PKA activation. 31, 32 To test this hypothesis, we inhibited G i with pertussis toxin (PTX, 1.5 mg/ml, 2 h). As a control, we verified that PTX effectively blocked the antiadrenergic effect of acetylcholine on the b 1 -AR-induced cytoplasmic PKA activation (see Supplementary material online, Figure S3A and B).
Under b 2 -AR stimulation, PTX-treated cells exhibited higher cytoplasmic PKA activity but no difference in nuclear PKA activation ( Figure 3A and B). Similarly, co-expression of AKAR3-NES or AKAR3-NLS with a C-terminal fragment of GRK2 (bARK-ct, see Supplementary material online, Figure S3C ), that scavenges bc subunits of heterotrimeric G proteins and prevents GRK2 phosphorylation and desensitization of the receptor, led to a potentiation of cytoplasmic PKA activity, but was without effect on nuclear PKA activity ( Figure 3C and D).
Another related mechanism for b 2 -AR compartmentalization is receptor localization to caveolae. 6, 8, 10 To address this possibility, caveolae were disrupted by treating the cells with methyl-b-cyclodextrin (MbCD, 2 mM, 1 h) to deplete cholesterol, or by co-expressing a dominant negative caveolin-3 mutant (Cav3DN) together with AKAR3-NES or AKAR3-NLS. 10 The efficiency of MbCD to deplete cholesterol was verified by filipin staining, whereas expression of Cav3DN was demonstrated by immunocytochemistry and western blot (see Supplementary material online, Figure S4A -C). In both cases, caveolae-disrupted cells showed potentiation of cytoplasmic but not nuclear PKA activity upon b 2 -AR stimulation ( Figure 3E-H) . Conversely, overexpression of wild type Cav3 induced a small decrease in b 2 -AR-stimulated cytoplasmic PKA activity, consistent with its previously reported effect on b 2 -ARgenerated cytoplasmic cAMP (see Supplementary material online, Figure  S4D ).
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Thus, inhibition of G i , of GRK2, and caveolae disruption potentiated b 2 -AR stimulation of PKA activity in the cell cytoplasm as expected, but did not confer PKA activation in the nucleus. Because recent studies emphasized the role of PDE3 and PDE4 in controlling the activation of discrete PKA pools by b 1 -and b 2 -ARs in cardiomyocytes, 33 we investigated the contribution of these enzymes to the regulation of cytoplasmic and nuclear PKA. We have shown previously in 26 that neither the PDE3 inhibitor cilostamide (Cil, 1 mM) alone nor the PDE4 inhibitor Ro-201724 (Ro, 10 mM) alone has an effect on basal PKA activity. Under b 1 -AR stimulation, PDE4 inhibition potentiated both cytoplasmic and nuclear PKA activities whereas PDE3 inhibition had no significant effect ( Figure 4A and B). In comparison, under b 2 -AR stimulation PDE3 inhibition led to a large potentiation of cytoplasmic PKA activity but was without effect on nuclear PKA activity ( Figure 4C and D) . Interestingly, PDE4 inhibition had a similar potentiating effect on cytoplasmic PKA activity under b 2 -AR stimulation but in this case it generated a strong nuclear PKA activation ( Figure 4C and D) . These results unveiled a critical role of PDE4 in controlling nuclear PKA activation. Figure 4E , b 1 -AR stimulation of isolated ARVMs led to a strong induction of ICER mRNA. This effect was potentiated by concomitant PDE4 inhibition, but not by PDE3 inhibition ( Figure  4E ). In comparison, b 2 -AR stimulation alone had no significant effect on ICER expression, but concomitant PDE4 inhibition resulted in ICER induction ( Figure 4F ). In the absence of b-AR stimulation, neither PDE3 nor PDE4 inhibition had effect on ICER mRNA expression (see Supplementary material online, Figure S5A ). b 1 -AR stimulation of ICER mRNA expression was not observed in cells transduced with an adenovirus encoding the selective PKA inhibitor peptide (PKI) (see Supplementary material online, Figure S5B ). To examine the specific contribution of nuclear vs. cytoplasmic PKA in ICER regulation, we fused the first 25 amino acids of PKI with the red fluorescent protein mCherry and appended either a 3 NLS or a NES at the C-terminus for nuclear or cytoplasmic targeting, respectively. As shown in the images and intensity profiles of Supplementary material online, Figure S6A was compared in Fura2-loaded and electrically paced ARVMs expressing cytoplasmic PKI, nuclear PKI or b-Gal. As shown in Supplementary Fig. 7 , b-AR stimulation with 10 nM Iso increased Ca 2þ transient amplitude to a similar extent in ARVMs expressing b-Gal or PKI-3NLS, whereas these effects were absent in ARVMs expressing PKI-NES. Interestingly, the cytoplasmic PKI completely blocked nuclear PKA activation in response to b 1 -ARs stimulation (see Supplementary material online, Figure S6D ). Both cytoplasmic and nuclear PKI also blocked ICER mRNA induction by b 1 -ARs ( Figure 5A ). These results show that upon b 1 -AR stimulation, PKA activation outside the nucleus is a prerequisite to enhanced nuclear PKA activity and ICER induction. The augmentation of ICER mRNA by b 1 -AR stimulation in combination with PDE4 inhibition was also suppressed by nuclear PKI expression ( Figure 5B) . Similarly, nuclear PKI completely blocked nuclear PKA activation by b 2 -ARs with concomitant PDE4 inhibition (see Supplementary material online, Figure S6E ). However, ICER mRNA induction by b 2 -ARs with concomitant PDE4 inhibition was only partially blocked by nuclear PKI, suggesting that alternative mechanisms contribute to this effect (see Supplementary material online, Figure 5C ). 35, 36 Because Epac1 was localized in the perinuclear region in cardiomyocytes, 18,37 similar experiments were conducted in cells pre-incubated with 10 mM of the Epac1 inhibitor, CE3F4. 38 However, as shown in Figure 5D , CE3F4 did not modify the stimulatory effect of b 2 -ARs þ Ro on ICER mRNA expression. In contrast, overexpression of PKI-NES abrogated ICER induction by b 2 -ARs with concomitant PDE4 inhibition, indicating that cytoplasmic PKA is required for ICER regulation by this receptor ( Figure 5E ). In cardiomyocytes, mAKAPb has been shown to organize a cAMPresponsive network containing PKA and PDE4 at the perinuclear membrane. 17 To study the contribution of mAKAPb in shaping nuclear PKA responses under b 1 -or b 2 -AR stimulation, we used adenoviruses expressing a short hairpin RNA (shRNA) to reduce its expression. 39 As shown in Figure 6A and B, this led to 50% decrease in mAKAPb perinuclear staining 72 h post-transduction. Downregulation of mAKAPb had no effect on the bulk cytoplasmic PKA activity under either b 1 -or b 2 -AR stimulation in the presence of Ro (see Supplementary material online, Figure S8 ). However, mAKAPb silencing induced a small decrease in b 1 -ARs stimulation of nuclear PKA activity ( Figure 6C ) which was not observed when PDE4 was inhibited ( Figure 6D) . Decreasing mAKAPb failed to unmask a nuclear PKA response to b 2 -AR stimulation ( Figure 6E ) but induced a 60% reduction of b 2 -AR þ Ro stimulation ( Figure 6F) . These results indicate that when PDE4 is inhibited, stimulation of b 2 -ARs activates a specific pool of PKA maintained by mAKAPb at the nuclear envelope to increase PKA activity inside the nucleus. This specific mAKAPb-dependent PKA pool may also be mobilized upon b 1 -AR stimulation, albeit contributing to total nuclear PKA activity to a much lesser extent.
Discussion
Numerous studies have emphasized the importance of spatiotemporal control of cAMP/PKA pools in specific subcellular compartments for physiological regulation of cardiomyocyte contractile function. By comparison, the mechanisms that control nuclear PKA activity are less well understood, despite their critical importance for modulation of gene expression and long term modification of cell growth and apoptosis by b-ARs. Here, we provide the first evidence that b 1 -and b 2 -ARs differentially activate nuclear PKA and gene expression in adult cardiomyocytes.
As illustrated in Figure 7 , we show that b 1 -AR stimulation engages PKA pools located outside the nucleus to enhance nuclear PKA activity and ICER expression, and that PDE4 is an important modulator of these responses. In the case of b 2 -ARs, our results are consistent with a model in which PDE4 insulates a mAKAPb-targeted PKA pool at the nuclear envelope that prevents nuclear PKA activation and ICER induction upon b 2 -AR stimulation. However, even if PDE4 inhibition unmasks an activation of PKA in the nucleus upon b 2 -AR stimulation, other mechanisms that depend on cytoplasmic PKA contributes to ICER regulation by b 2 -AR stimulation when PDE4 is inhibited.
In this study we found that under selective b 1 -AR stimulation, PKA was activated in both the cytoplasmic and nuclear compartments, whereas b 2 -AR stimulation was less efficient to activate cytoplasmic PKA and failed to activate nuclear PKA. The slower kinetics of nuclear vs. cytoplasmic PKA activation observed upon b 1 -AR stimulation are consistent with previous observations using Iso in cardiomyocytes 26, 27 and suggest that the PKA holoenzyme is first activated outside the nucleus and then the catalytic subunits translocate inside the nucleus by diffusion, which is a slow process. 40 The fact that cytoplasmic PKI abolished PKA phosphorylation of the nuclear-targeted PKA biosensor and induction of ICER upon b 1 -AR stimulation supports this model and argues against the contribution of a nuclear resident pool of PKA as demonstrated in HEK293 cells. 15 These results also offer a complementary view to the local-activation/local-action of PKA signalling which prevails in other subcellular compartments of cardiomyocytes. The robust increase in cytoplasmic PKA activity observed here for b 1 -ARs compared with the smaller b 2 -AR effect is consistent with previous real-time monitoring of PKA activity in mouse ventricular myocytes. 41 However, this difference is not sufficient to explain the lack of nuclear PKA activation by b 2 -ARs since for a similar increase in cytoplasmic PKA activity, b 1 -but not b 2 -ARs activate nuclear PKA ( Figure 1G) . Thus, compartmentalization rather than intensity of b 2 -AR signals must explain their inability to induce nuclear PKA activation. However, our cAMP measurements with a fourth-generation cAMP FRET sensor harboring a superior dynamic range 30 clearly showed that b 2 -AR stimulation elevated cAMP in the nucleus. This result was not expected given a previous report that b 2 -AR stimulation generates locally confined cAMP signals. 29 However, a recent study using the same biosensor suggests that cAMP diffusivity is equivalent upon non-selective b-AR or selective b 2 -AR stimulation. 42 Thus, one possibility is that the cAMP generated by b 2 -AR stimulation is able to diffuse to the nucleus even if the receptor and organelle are located at some distance from each other. But alternatively, b 2 -ARs could be localized in close proximity to the nucleus in ARVMs. Indeed, b 2 -ARs were shown to be located in T-tubules, 9 and T-tubules are known to extend from the cell surface to the nuclear envelope, where they establish close contacts with the nucleus. 43, 44 Previous studies have proposed that alternative coupling of b 2 -ARs to G i and their localization to caveolae circumvent b 2 -AR signalling by acting not only at the level of cAMP, but also downstream, by activating phosphatases. 8, 31, 32 Accordingly, inhibition of G i or disruption of caveolae potentiated b 2 -AR responses in the cytoplasm. However, these manoeuvres failed to unmask an effect of b 2 -AR stimulation on nuclear PKA activity, making it unlikely that phosphatase activation would explain the lack of b 2 -AR response in this compartment. Similarly, we show that bARK-ct overexpression potentiates b 2 -AR-induced cytoplasmic but not nuclear PKA activity. The former is consistent with inhibition of b 2 -AR desensitization, and consequent increased G s signalling, but could also be explained by a decrease in G i signalling, since it has been shown that GRK2-mediated phosphorylation of b 2 -ARs is important for b 2 -AR coupling to G i . 45, 46 In addition, bARK-ct should also prevent the recruitment of PDE4D5 to b 2 -ARs 47 as recently demonstrated. 48 Based on our results, failure of b 2 -ARs to increase nuclear PKA activity was not due to coupling of b 2 -ARs to PDE4D5. Altogether, these data demonstrate that nuclear PKA activity can be dissociated from the bulk cytoplasmic PKA activity upon b 2 -AR stimulation, and that none of the above mechanisms is sufficient to explain the lack of nuclear PKA activation upon b 2 -AR stimulation.
It is undisputed that higher rates of local cAMP degradation by PDEs participate in curtailing cAMP signal. 49 For this reason, we investigated the role of PDE3 and PDE4, the two major cAMP-hydrolyzing PDEs expressed in rat cardiomyocytes, 12 in tuning cytoplasmic and nuclear PKA responses to b-AR stimulation. Our findings show that PDE3 plays a minor role in regulating b 1 -AR stimulation, but controls cytoplasmic PKA activity in response to b 2 -AR stimulation, whereas PDE4 acts as the main modulator of PKA activity under both b 1 -and b 2 -AR stimulation. These data are consistent with earlier work showing that PDE4 regulates cAMP levels under both b 1 -and b 2 -AR stimulation, whereas PDE3 preferentially regulates cAMP generated under b 2 -AR stimulation. 29 Strikingly, PDE4 inhibition unmasked nuclear PKA activation under b 2 -AR stimulation. Although several PDE4 isoforms were shown to be associated with b 2 -ARs, 47,50 our cAMP measurements are not compatible with PDE4 preventing cAMP generated by b 2 -AR stimulation to access the nucleus. Hence, we reasoned that PDE4 may act as a sink, isolating a discrete PKA pool from cAMP influx generated upon b 2 -AR stimulation. 51 In cardiomyocytes, a perinuclear pool of PKA is maintained together with PDE4D3 by the scaffolding protein mAKAPb, localized at the external membrane of the nuclear envelope, 17 a strategic position for nuclear regulation. Our results show that disrupting this PKA pool by mAKAPb knockdown drastically reduced nuclear PKA activation by b 2 -ARs with concomitant PDE4 inhibition. This identifies mAKAPbassociated PKA as the main route for b 2 -AR control of nuclear PKA. The co-localization of PDE4D3 and PKA within the mAKAP complex allows efficient activation of PDE4D3 by PKA, rapid degradation of cAMP and restoration of basal PKA activity. 17 In line with recent studies suggesting that PKA activation within an AKAP complex does not involve dissociation of the catalytic subunits, 52, 53 PDE4D3 within the mAKAP complex may prevent catalytic subunit dissociation and their translocation inside the nucleus, hence explaining the lack of nuclear PKA activation by b 2 -ARs. Upon PDE4 inhibition, abnormally elevated cAMP levels are reached in the complex, allowing PKA catalytic subunit dissociation and transfer to the nucleus. We have previously demonstrated that mAKAPb selectively binds Type 5 AC (AC5) in cardiomyocytes 54 and others have shown that this AC5 is localized in T-tubules and is critical for b 2 -AR enhancement of I Ca, L which is revealed by application of PDE3 and PDE4 inhibitors. 11 This parallel with our results further supports the existence of a pool of b 2 -ARs localized at the interface between the T-tubular membrane and the nuclear envelope ( Figure 7) . The small impact of mAKAPb silencing on b 1 -AR stimulation of nuclear PKA activity suggests that other PKA pools are involved, which may be controlled by distinct AKAPs. One possible candidate is AKAP-Lbc, which is localized in a relatively broad perinuclear region in neonatal myocytes. 55 Indeed, AKAP-Lbc was recently shown to bind a PDE4 long isoform, the activation of which led to reduced forskolin-induced nuclear PKA activation and attenuated hypertrophic response to b-AR stimulation. 56 Recent studies have emphasized the critical role of PKA in the proapoptotic effects of b-ARs. 57 We have shown that nuclear PKA activation by b 1 -ARs is concentration-dependent (Figure 1) , requires sustained receptor stimulation, 26 and induces ICER expression ( Figures 4E and 5A ), which is a strong mediator of apoptosis by decreasing Bcl-2 in cardiomyocytes. 21 In contrast, b 2 -ARs do not increase nuclear PKA activity ( Figure 1 ) and fail to increase ICER expression ( Figure 4F ). These results are consistent with a previous study showing that cardiomyocyte fate is switched from survival to death depending on the strength of b-AR stimulation and the balance between a b 2 -AR/G i -mediated ERK1/2 pathway leading to Bcl-2 induction at a low concentration range of Iso, and a b 1 -AR-mediated PKA/CREB/ICER pathway leading to Bcl-2 repression at higher concentrations of Iso. 34 Thus, segregated PKA activation between the cytoplasm and the nucleus, together with activation of surviving signalling such as ERK1/2 is likely to contribute to the differential effects of low vs. high levels of b-AR stimulation as well as subtype-specific effects. However, we further show that b 2 -ARs can increase ICER expression when PDE4 is inhibited ( Figure 4F ). At variance with b 1 -ARs, this effect was only partially inhibited by nuclear PKI. It was not modified by the Epac1 inhibitor CE3F4 ( Figure 5D ), but could be almost completely abrogated by cytoplasmic PKI ( Figure 5E ). These results suggest that an alternative pathway depending on cytoplasmic but not nuclear PKA activity contributes to ICER induction by b 2 -ARs when PDE4 is inhibited. In neurons, PKA is required for nuclear translocation of ERK and ribosomal S6 kinase 2 and subsequent stimulation of CREB-dependent transcription. 58 Further studies are needed to determine if a similar cross talk exists in cardiomyocytes. Nevertheless, the present results underline the fact that b 1 -ARs and b 2 -ARs trigger divergent signalling mechanisms to regulate gene expression in cardiomyocytes. In a previous study, it was shown that in neonatal cardiomyocytes, PDE3 but not PDE4 inhibition increased CREB phosphorylation and ICER expression and thus induced Bcl-2 downregulation. 22 These results contrast with the lack of effect of the PDE3 inhibitor cilostamide on basal ICER expression observed here (see Supplementary material online, Figure S5A ). This might be explained by differences in experimental conditions or the cell type used (adult vs. neonatal myocytes).
In conclusion, our study unveils the molecular mechanisms by which b 1 -and b 2 -ARs differentially regulate nuclear PKA activity and ICER expression in terminally differentiated adult cardiomyocytes, and identify mAKAPb and PDE4 as critical organizers of b 2 -AR nuclear signalling. Many questions remain, however, that will need to be addressed in future studies. The extent to which the findings obtained here for ICER can be generalized to the b-AR transcriptome, and the place of PKA in the control of gene expression by b-ARs vs. other cAMP effectors will deserve further investigations. The contribution of intracellular b-ARs located at the nuclear envelope, 59 ,60 in endosomes, 61 and at the Golgi 61, 62 Nuclear PKA regulation by b-ARs in cardiomyocytes should be evaluated in intact adult cardiac myocytes. In a translational perspective, it will also be important to determine whether the signalling routes linking b-ARs to nuclear PKA activation identified here in rat are conserved in larger mammals and humans. 
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